Stifel analyst Justin Keywood maintained his “Buy” rating and C$9.00 target price for WELL Health Technologies (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL) in a Sept. 29th note, arguing that recent Canadian healthcare take-outs highlight a disconnect between public market valuations and fair value for assets with strong secular tailwinds. He pointed to […]
Stifel analyst Justin Keywood says Canada’s aging population and the government’s commitment of more than $50-billion in new healthcare investment this year are setting the stage for undervalued healthcare infrastructure plays to re-rate higher. In a Sept. 18 report titled ‘Out With the New, In With the Old: Our Top Opportunities For Canadian Healthcare Infrastructure […]
Share
Tweet
Share
